❭ Research by medical division ❭ Laboratory Medicine ❭ Dept. of Immunology

Department of Immunology

Head of department: John Torgils Vaage
Head of research: Ludvig A. Munthe

Research groups:

Adaptive Immunity and Homeostasis

Jan Terje Andersen

Molecular immunology and vaccine development

Ranveig Braathen

Norwegian Center for Stem Cell Research

Joel Glover
Director NCS
 

Computational and Systems Immunology

Victor Greiff

Influenza and Adaptive Immunity

Gunnveig Grødeland

Autoimmunity and B-cell biology

Rasmus Iversen

Laboratory of Immunoregulation and T Cell Biology 

Johanne Tracey Jacobsen

 Cell Signalling Research Group 

Stefan Krauss

Protein Array Group 

Fritdjof Lund-Johansen

The Complement Research Group 

T. E. Mollnes

Blood and Lymphoproliferative Diseases 

Ludvig A. Munthe

Blood donation, transfusion and immunomodulation 

Lise Sofie Haug Nissen-Meyer

Cell Signalling Networks in Innate Immunity 

Tuula Anneli Nyman

Molecular Immunology by Receptor and Transcriptomics Analysis 

Shuo-Wang Qiao

Functional Immunogenetics 

Ludvig Sollid

B-Cell Receptor signaling Group 

Peter Szodoray

Cell Signaling and Drug Discovery

Jo Waaler

 

 
Scroll to top

Home Laboratory Medicine Dept. of Immunology

  • Adaptive Immunity and Homeostasis (Andersen)
  • Molecular immunology and vaccine development (Braathen)
  • Norwegian Center for Stem Cell Research (Glover)
  • Computational and Systems Immunology (Greiff)
  • Influenza and Adaptive Immunity (Grødeland)
  • Autoimmunity and B-cell biology
  • Laboratory of Immunoregulation and T Cell Biology (J.T. Jacobsen)
  • Cell Signalling Research Group (Krauss)
  • Protein Array Group (Lund-Johansen)
  • Complement (Mollnes)
  • Blood and Lymphoproliferative Diseases (Munthe)
  • Blood donation, transfusion and immunomodulation (Nissen-Meyer)
  • Cell Signalling Networks in Activation of Innate Immunity (Nyman)
  • Molecular Immunology by Receptor and Transcriptomics Analysis (Qiao)
  • Functional Immunogenetics (Sollid)
  • B-Cell Receptor signaling Group (Szodoray)
  • Cell Signaling and Drug Discovery (Waaler)
  • IMMI Staff
  • Publications, annual summary

Recent publications

Wilson M, Michalsen H, Anke A, Pedersen SG, Espinasse M, Langeland N, Cox RJ, Aukrust P, Dahl TB, Sandvig A, Wilhelmsen M (2026)
Effectiveness of tailored individual follow-up vs. standard one-day group course on health-related quality of life in patients with post COVID-19 condition: a randomized controlled trial
Front Rehabil Sci, 7, 1927300
DOI 10.3389/fresc.2026.1927300, PubMed 42840070

Cung T, Pischke SE, Schjalm C, Mülleder B, Willems L, Sonnleitner M, Toonen EJM, Mollnes TE, Barratt-Due A (2026)
Correction: Point-of-care assessment of complement activation in the ICU: a feasibility study of rapid terminal complement complex detection in critical illness
Front Immunol, 17, 1984508
DOI 10.3389/fimmu.2026.1984508, PubMed 42812690

Færden IH, Bliksøen M, Schjalm C, Pettersen K, Liavåg OMIB, Majeed WM, Hagness M, Mollnes TE, Pischke SE (2026)
Immune activation during liver machine perfusion is shaped by perfusate composition and is independent of the ischemic injury
Front Immunol, 17, 1874888
DOI 10.3389/fimmu.2026.1874888, PubMed 42807186

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)